Navigation Links
Collagen Matrix, Inc. Receives FDA 510(k) Clearance for New Collagen Dental Membrane Based on Porcine Collagen Platform Technology
Date:10/1/2010

ses of this new material are broad and add yet another dimension to the breadth of collagen expertise in the Company's intellectual property.  This is another platform on which we plan to build and innovate for future products in key areas of growth," said Shu-Tung Li, Ph.D., Founder and CEO of Collagen Matrix.

Collagen Matrix, Inc. is a leader in the design and engineering of collagen- and mineral-based extracellular matrices for tissue and organ repair and regeneration.  Since its inception in 1997, the Company has received many government grants for the development of collagen-based matrix products in the areas of neurological, vascular, urological, and orthopedic tissue regeneration applications.  The Company currently manufactures collagen-based finished medical devices in the areas of neurosurgery, oral surgery, orthopedic-spine surgery, and wound care.  More information about the Company can be found at www.collagenmatrix.com.

Contact: Peggy Hansen, RAC

 Vice President, Clinical, Regulatory, Quality Assurance, and Marketing


'/>"/>
SOURCE Collagen Matrix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Biosynthetic corneas formulated with recombinant collagen restore vision and nerve growth
2. Important Step Forward in Osteoarthritis Research: Bioactive Collagen Peptides Stimulate the Regeneration of Cartilage Tissue
3. Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler
4. Xiaoguang Meng receives honorary master of engineering from Stevens
5. AMT Receives Orphan Drug Designation From the U.S. Food and Drug Administration Duchenne Muscular Dystrophy Gene Therapy
6. Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010
7. NephRx Corp. Receives Orphan Drug Designation for NX001 for Prevention of Delayed Kidney Graft Function
8. MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
9. NanoSmartâ„¢ Pharmaceuticals, Inc. Receives Patent Allowance for Tumor Targeting Platform Technology
10. Renhuang Receives AAA(1) Rating from Chinese Academy of International Trade & Economic Cooperation of Ministry of Commerce
11. Keck Graduate Institute Receives $3.6 Million NIH Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015  BioClinica®, Inc., a leading specialty ... announced that clinical trial professionals representing 20 ... annual European User Conference in ... use of its eClinical technologies to overcome ... the Microsoft Office-Smart OnPoint CTMS; Express EDC; ...
(Date:3/4/2015)... March 4, 2015 Launched ... Paris in December 2011, ,SARAH, - ... resin microspheres versus sorafenib in advanced hepatocellular carcinoma (HCC) ... 2016.   SARAH, a large French study ... carcinoma, or HCC) has completed patient enrolment, exceeding its ...
(Date:3/3/2015)... 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, ... molecular diagnostics that target the underlying mechanisms of cancer, ... period ended December 31, 2014. Effective July ... from May 31 to December 31. As a result ... are for the quarter and the seven months ended ...
(Date:3/3/2015)... 03, 2015 Experts and industry insiders ... one event: the Alltech REBELation exploring innovation, inspiration and ... Now in its 31st year, Alltech’s annual international conference ... and the opportunity to join the REBELation at an ... 11:59 p.m. EST, at which point the standard early ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... , VANCOUVER, Aug. 20 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ... the commercial launch of the Option(TM) Inferior Vena Cava ... clearance in June and a limited pre-launch in July. ... the Option IVC Filter, which it obtained in a ...
... ... and will include the synthesis of cyclic peptides employing a unique safety-catch linker, which ... ... METTLER TOLEDO will sponsor a free webinar, Innovative Approaches to Synthesis and ...
... REINACH, Switzerland, August 19 Arpida Ltd,(SIX: ARPN) announced ... , Key events 2009 to date, ... - Strategic options under review, - Company restructuring ... 22.7 million at 30 June 2009 , CFO ...
Cached Biology Technology:Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States 2Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States 3Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States 4Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States 5Synthesis and Purification of Peptide Libraries -- Innovative Approaches 2Arpida Reports Interim Results For Six Months to 30 June 2009 2
(Date:2/24/2015)... This report analyzes the worldwide markets for Iris ... for the US, Canada , ... Asia-Pacific , Middle East , and ... are provided for the period 2013 through 2020. Also, a ... and analytics are derived from primary and secondary research. Company ...
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: CPHD ... the following conferences, and invited investors to participate via webcast. ... Boston, MA Tuesday, March 3, 2015 at 11.20 ... Orlando, FL Wednesday, March 4, 2015 ... To access the live webcasts for these events, please visit ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25
... their characteristic calls remains largely a biological mystery, ... a valuable way to track the movements of ... with hydrophones (underwater microphones), deployed in remote waters ... to track seasonal occurrences of blue, fin, humpback, ...
... of conservation groups battling global extinctions has saved one ... , American Bird Conservancy (ABC), Conservation International (CI), and ... 1,600-acre site on the northwest slope of the Sierra ... of Colombia, before its development for vacation homes. , ...
... potentially life threatening in the home, but the presence of ... Steven and colleagues from the University of Nottingham have found ... as an early warning of leaks in natural gas pipelines. ... remote systems to monitor gas leaks via the spectrum of ...
Cached Biology News:Underwater listening devices yield discoveries about endangered large whales 2Crucial site for endangered frogs and birds saved 2Plants used to detect gas leaks, from outer space! 2
... is a fluorescent nucleic acid dye which ... As a nuclear counterstain, propidium iodide stains ... color. The fluorescent red color provides ... such as FITC, Cy2 or AMCA. ...
... cultured in DMEM and harvested at the log ... the antigens in their native forms, cells were ... on a 12-well (5 mm) adhesive coated slide, ... cellular attachment and to minimize background staining. ...
...
... Application: Acridine orange has been used as ... agarose and polyacrylamide gels. Acridine orange at ... purified DNA in gels with a sensitivity ... also been used extensively for cell staining ...
Biology Products: